Patents Assigned to FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA
  • Publication number: 20220152184
    Abstract: The invention refers to a composition comprising inactivated cells deficient in LPS from the genus Acinetobacter and/or outer membrane vesicles form the same and their use for the manufacture of a medicament, preferably a vaccine, for the prevention of diseases produced by organisms of the genus Acinetobacter.
    Type: Application
    Filed: September 29, 2021
    Publication date: May 19, 2022
    Applicants: VAXDYN S.L., FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA, SERVICIO ANDALUZ DE SALUD
    Inventors: Michael James McConnell, Meritxell García Quintanilla, Marina Pulido Toledano, María Pilar Pérez Romero, Jerónimo Pachón Díaz, Juan José Infante Viñolo
  • Patent number: 11160856
    Abstract: The invention refers to a composition comprising inactivated cells deficient in LPS from the genus Acinetobacter and/or outer membrane vesicles form the same and their use for the manufacture of a medicament, preferably a vaccine, for the prevention of diseases produced by organisms of the genus Acinetobacter.
    Type: Grant
    Filed: January 24, 2018
    Date of Patent: November 2, 2021
    Assignees: Vaxdyn S.L., Fundación Pública Andaluza para la Gestión de la Investigación en Salud De Sevilla, Servicio Andaluz de Salud
    Inventors: Michael James McConnell, Meritxell García Quintanilla, Marina Pulido Toledano, María Pilar Pérez Romero, Jerónimo Pachón Díaz, Juan José Infante Viñolo
  • Publication number: 20190194749
    Abstract: The invention relates to a method for the diagnosis of liver fibrosis, comprising detecting the level of expression of the gene GATA-4, or the quantity of the protein GATA-4, in the isolated biological sample of liver tissue. The invention also relates to a diagnosis kit.
    Type: Application
    Filed: April 30, 2014
    Publication date: June 27, 2019
    Applicants: UNIVERSIDAD PABLO DE OLAVIDE, UNIVERSIDAD DE SEVILLA, SERVICIO ANDALUZ DE SALUD, FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA
    Inventors: Ana Isabel Rojas Gonzalez, David Cano Gonzalez, Irene Delgado Sainz, Bernat Soria Escoms, Francisco Martin Bermudez, Manuel Romero Gomez
  • Publication number: 20180256700
    Abstract: The invention refers to a composition comprising inactivated cells deficient in LPS from the genus Acinetobacter and/or outer membrane vesicles form the same and their use for the manufacture of a medicament, preferably a vaccine, for the prevention of diseases produced by organisms of the genus Acinetobacter.
    Type: Application
    Filed: January 24, 2018
    Publication date: September 13, 2018
    Applicants: VAXDYN S.L, FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA, SERVICIO ANDALUZ DE SALUD
    Inventors: Michael James McConnell, Meritxell García Quintanilla, Marina Pulido Toledano, María Pilar Pérez Romero, Jerónimo Pachón Díaz, Juan José Infante Viñolo
  • Publication number: 20170065700
    Abstract: The invention refers to a composition comprising inactivated cells deficient in LPS from the genus Acinetobacter and/or outer membrane vesicles form the same and their use for the manufacture of a medicament, preferably a vaccine, for the prevention of diseases produced by organisms of the genus Acinetobacter.
    Type: Application
    Filed: May 5, 2015
    Publication date: March 9, 2017
    Applicants: VAXDYN, S.L., FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA, SERVICIO ANDALUZ DE SALUD
    Inventors: Michael James McConnell, Meritxell García Quintanilla, Marina Pulido Toledano, María Pilar Pérez Romero, Jerónimo Pachón Díaz, Juan José Infante Viñolo